Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimens by Xiao Liu, Shuangshuang Jia, Yuping Chu, Biao Tian, Yaya Gao, Chunyan Zhang, Yanhua Zheng, Weijing Jia, Xiangxiang Liu, Ruifeng Yuan, Na Zhang, Juan Feng, Hongjuan Dong, Xiaoli Xin, Ziwei Chang, Zhengcong Cao, Hailong Tang, Guangxun Gao

Get full text